Angola

in page functions
[French]
Angola
Total population (2017) 26,655,481
Birth cohort (2017) 1,177,093
Surviving Infants (surviving to 1 year per year, 2017) 1,072,891
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 96/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 157/1000
Gross Nation Income (per capita US$, 2015) 4,180
Co-financing group (2017) Accelerated transition
No. of districts/territories (2016) 166

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Angola

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Total $113,194,911 $113,194,911 $112,599,410
Graduation grant (GG) $1,463,052 $1,463,052 $1,425,074 97%
Health system strengthening (HSS 1) $3,969,999 $3,969,999 $2,920,109 74%
Immunisation services support (ISS) $2,988,000 $2,988,000 $2,988,000 100%
Injection Safety Devices (NVS) $391,500 $391,500 $495,190 126%
Injection safety support (INS) $1,252,610 $1,252,610 $1,252,610 100%
IPV (NVS) $1,688,501 $1,688,501 $445,076 26%
MR-Catch-up campaign (NVS) $4,554,500 $4,554,500 $4,600,651 101%
Penta (NVS) $54,736,377 $54,736,377 $55,040,963 101%
Pneumo (NVS) $30,266,817 $30,266,817 $31,454,165 104%
Rotavirus (NVS) $8,139,555 $8,139,555 $8,233,679 101%
Vaccine Introduction Grant (VIG) $3,744,000 $3,744,000 $3,743,893 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Angola DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 80%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2007) 36.80%
Household survey: DTP3 coverage for female (2007) 38.40%
Household survey: Last DTP3 survey (2007) 38%
% districts achieving > 80% DTP3 coverage (2016) 54%
% districts achieving < 50% DTP3 coverage (2016) 11%
MCV WHO/UNICEF estimates (2016) 49%

Breakdown of support

Non-vaccine support Vaccine support
11% 89%
$12,329,686 $100,269,724

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Angola

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

30 November 2017

Gavi Board Dec 2017 - Nasala village visit

Millions of children set to be protected against typhoid fever

Gavi Board approves US$ 85 million funding window for 2019-2020 to support the introduction of typhoid conjugate vaccine in developing countries.

23 May 2017

Seth Q&A 1

The Best Intervention: Gavi CEO Seth Berkley's Q&A, Part I

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this first article, Seth describes Gavi’s latest priorities, highlights the increased risk of epidemics starting in densely populated urban slums and emphasises the need to reach every child with all WHO-recommended vaccines.

close icon

modal window here